Preoperative Immunonutrition in Patients Undergoing Spine Surgery

Last updated: May 4, 2023
Sponsor: Istituto Ortopedico Galeazzi
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteoarthritis

Treatment

Immuno-nutrition

Clinical Study ID

NCT05372289
ORTHOPACT (PI: M Briguglio)
L4144
  • Ages > 60
  • All Genders

Study Summary

A malnutritional status is known to be associated with altered immune function, reduced function, and worsen outcomes after orthopedic surgery. Medical and surgical complications are not uncommon in Orthopedics and infection rates are potentially life-threatening complications, with the highest morbidity, mortality, and healthcare costs. Most patients undergoing orthopedic surgery are elderly, malnourished, osteosarcopenic, sedentary, anemic, and suffer from low levels of vitamin D. A mono-nutrient supplement may be not sufficient for supporting the arthrodesis techniques, which are invasive open surgeries procedures with significant blood losses and the need of transfusions. In this therapeutic area, immuno-nutrition has been used in spine surgery, with the reduction of complications, revisions, and readmissions. In addition, prosthetic surgery outcomes have been observed to ameliorate by using this nutritional support. Therefore, preoperative oral immuno-nutrition therapy may be applied in older adults undergoing spine surgery to improve patients' outcomes and reduce complications.

This is a randomized, controlled, open-label, 2-arm non-parallel-group, single-center interventional study to assess the efficacy of an immuno-nutrition therapy vs. hospital standard of care in spine surgery to improve patients' outcomes. This is a single primary endpoint study. A total of 136 patients from IRCCS Orthopedic Institute Galeazzi in Italy will be recruited and assigned in a 1:1 ratio to the treatment arm.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • male and female sex, of all ethnicities, aged over 60
  • arthrodesis involving ≥ 6 vertebrae
  • American Society of Anesthesiology (ASA) risk: 1, 2, or 3
  • Absence of neurological or psychiatric disorders
  • Signing of informed consent and consent to collaborate in all study procedures
  • Patients who meet the clinical requirements to undergo their first spinal surgery

Exclusion

Exclusion Criteria:

  • American Society of Anesthesiology (ASA) risk: 4
  • No cervical arthrodesis
  • Diagnosis of neurological or psychiatric disorders
  • Revisions
  • Therapy with other supplements at the time of the first visit 0
  • Known allergy or adverse food reactions
  • Chronic inflammatory or autoimmune diseases (e.g. rheumatoid arthritis)
  • Gastrointestinal disorders
  • Conditions that do not allow to undergo surgery

Study Design

Total Participants: 136
Treatment Group(s): 1
Primary Treatment: Immuno-nutrition
Phase:
Study Start date:
March 16, 2022
Estimated Completion Date:
February 29, 2024

Connect with a study center

  • IRCCS Istituto Ortopedico Galeazzi

    Milan,
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.